Food
Commented by Carsten Mainitz on August 19th, 2026 | 07:55 CEST
Weight-Loss Boom 2.0: BioNxt Solutions, Novo Nordisk and Nestlé Are Growing in a Billion-Dollar Market
The weight-loss injection has not only transformed the pharmaceutical market but is also gradually impacting the food industry. The prescription drug semaglutide, used to treat type 2 diabetes and obesity, is at the forefront of this trend. The active ingredient mimics the body's own gut hormone GLP-1, thereby achieving several desired effects. It increases feelings of fullness, reduces appetite, slows gastric emptying, and improves insulin secretion. Meanwhile, innovative specialists such as BioNxt Solutions are positioning themselves by advancing alternative and improved drug delivery methods. The Canadian company is developing thin films of active ingredients that dissolve under the tongue and are intended to replace medications administered via injection or traditional tablets. The news flow is promising. At the same time, Nestlé is creating a new food category for people who want to lose weight using GLP-1 preparations. Who has the edge?
Read
Commented by Jens Castner on August 12th, 2026 | 07:30 CEST
Buckle Up for a Short Squeeze: Could Almonty and HelloFresh Follow SpaceX's Rocket Launch?
When short sellers are caught off guard, it can lead to veritable price explosions. Although no supernova was observed at the aerospace company SpaceX last week, it was definitely more than a gentle liftoff: the share price shot up by more than 15% following its quarterly results. Notably high short positions have also recently built up for the tungsten producer Almonty Industries and the meal-kit delivery service HelloFresh. With earnings reports just around the corner for both stocks, these numbers could become the catalyst for an even bigger move.
Read
Commented by Armin Schulz on August 7th, 2026 | 07:25 CEST
Bayer, MustGrow Biologics, and Nutrien: Feeding the World Means Leading the Future of Agriculture
Created and Published on Behalf of MustGrow Biologics Corp.
Global food security remains under pressure from geopolitical conflicts, extreme weather events, and resource scarcity. These challenges are placing agricultural production under growing strain. With the world's population continuing to expand, transforming agriculture has become a critical priority. As a result, the agricultural technology sector is emerging as a key driver of innovation. Established industry leaders are adapting their product portfolios to meet the demands of a changing climate, while agile biotech companies are accelerating the development of sustainable alternatives to conventional chemical crop protection products. Today, we take a closer look at Bayer, MustGrow Biologics, and Nutrien—three companies that are well positioned to shape the future agricultural value chain.
Read
Commented by André Will-Laudien on August 1st, 2026 | 07:05 CEST
AI and Smart Farming: Growth Opportunities with BASF, MustGrow, SAP, and Nestlé
Created and Published on Behalf of MustGrow Biologics Corp.
Devastating wildfires in Spain and southern France are no longer a rare occurrence. Climate change is taking an increasing toll. Alongside technological progress, we must ensure that the natural resources we depend on—clean water, clean air, and healthy ecosystems—are preserved for future generations. The smart farming approach is transforming agriculture through the targeted use of digital technologies such as drones, artificial intelligence (AI), and IoT sensors. These innovations enable farms to precisely manage resources like water and energy while improving yield forecasting and operational efficiency. A key pillar of this transformation is a stronger focus on sustainability and the protection of natural ecosystems. From this perspective, biological fertilizers are becoming increasingly important, as they help maintain long-term soil health, unlike many synthetic alternatives. Investors stand to benefit in more ways than one. Companies that combine sustainability with technological innovation are well positioned to capitalize on powerful long-term trends. In this report, we take a closer look at the opportunities.
Read
Commented by André Will-Laudien on July 1st, 2026 | 06:50 CEST
Here We Go: A Breakthrough for Bayer, Buy Signals for MustGrow and Kraft Heinz
Created and Published on Behalf of MustGrow Biologics Corp.
According to United Nations projections, the world's population is expected to grow to around 9.7 billion people by 2050. The Food and Agriculture Organization (FAO) estimates that this growth can only be managed with significantly more productive and, at the same time, more sustainable farming methods. This is where MustGrow Biologics comes in with biological crop solutions based on natural mustard extracts. And the company's growth story is only just beginning. The sector is gaining short-term momentum now that Bayer has finally received a positive ruling from the US Supreme Court regarding glyphosate. This should allow the Leverkusen-based company's Crop Science division to really take off. At the same time, a powerful structural trend is reshaping the entire agricultural value chain. Natural resources and food must be produced more sustainably and with greater resilience to meet the nutritional needs of a rapidly growing global population. Companies such as Kraft Heinz are responding by leveraging decades of expertise in building resilient agricultural supply chains and climate-adaptive farming systems. These are exciting developments in a sector that is often overlooked in the shadow of high-tech and defence. But the technological trends have long since shifted!
Read
Commented by Jens Castner on June 26th, 2026 | 07:30 CEST
Idolized, Sold Off, Forgotten: What is Next for Coinbase, HelloFresh, and American Atomics
On the stock market today, more than ever, greed clouds judgment. When a trend persists long enough, the market begins to treat it as a law of nature—projecting growth rates into a future they are unlikely to sustain. Coinbase, HelloFresh, and American Atomics illustrate this dynamic in very different ways: from a leveraged crypto bet to a pandemic winner in decline to a uranium explorer that is arguably mispriced based on spot commodity sentiment. Now, far removed from their peak euphoria, all three are largely trading out of the spotlight. This raises a central question: which of these stocks deserves a second look?
Read
Commented by Carsten Mainitz on June 4th, 2026 | 07:45 CEST
Takeover Fever! BioNxt Solutions, Delivery Hero, and Commerzbank in the Spotlight: How Investors Can Benefit!
The entry of a strategic investor or the prospect of a takeover regularly leads to significant price surges and even massive revaluations. The momentum is enormous; the global market for mergers and acquisitions has reached new records. Especially during periods of technological upheaval, geopolitical realignment, and increasing competitive pressure, companies are increasingly turning to acquisitions to secure growth, resources, or market share. In this context, there are exciting and lucrative developments for investors at BioNxt Solutions, Delivery Hero, and Commerzbank. The investment case for BioNxt Solutions is particularly compelling. The Canadian company aims to bring an alternative to weight-loss injections to market. If successful, this could create a billion-dollar business and attract acquirers. How should investors position themselves?
Read
Commented by Matthias Schomber on May 14th, 2026 | 07:55 CEST
Bayer and BASF on a Performance High — and MustGrow Biologics as a Secret Weapon Against World Hunger!
Created and published on behalf of MustGrow Biologics Corp.
The world's population is growing inexorably, and with it the demand for efficient—but above all sustainable—solutions in agriculture. While the German heavyweights Bayer and BASF have recently impressed markets with strong performance and further cemented their dominant positions, a smaller player is preparing to emerge from the slipstream of the industry giants and join the major leagues. Hardly anyone is likely to have this stock on their radar yet, but it would be worth at least adding it to the watchlist. MustGrow Biologics may have endured a difficult stretch on the stock market, but recent strategic decisions and regulatory successes suggest that the company could be delivering the right answers to pressing global food security challenges at exactly the right time. The market currently appears to be bottoming out, which could mark an attractive entry point for risk-tolerant investors before the biological agriculture trend gains further momentum. In this report, we examine the latest developments at these three companies in the battle for the farmland of the future.
Read
Commented by André Will-Laudien on April 21st, 2026 | 06:55 CEST
Middle East Conflict Weighs on Markets: Food Supply Chains Become a Key Issue – MustGrow, K+S, Evotec, and BioNTech in the Spotlight
The Middle East conflict is once again bringing global supply chains into focus and increasing pressure on vulnerable supply routes. The Strait of Hormuz, in particular, remains a key geopolitical risk factor because it is of great importance for the global flow of goods and energy. If tensions arise there, transportation costs, delivery times, and price fluctuations can quickly escalate. This creates new opportunities as well as risks, particularly for companies involved in food, health, and agricultural technology. MustGrow and K+S ensure the global food supply through fertilizers, while Evotec and BioNTech operate in the complex landscape of health-related issues. Despite uncertain conditions, dynamic investors are keeping an eye on the stocks that deliver comparatively robust results in a volatile market environment. We dig a little deeper!
Read
Commented by Armin Schulz on February 2nd, 2026 | 07:40 CET
BASF, MustGrow Biologics, and K+S Alliance: How to benefit from the megatrend of food security
Global food security is facing a historic stress test. Driven by population dynamics, climate extremes, and geopolitical upheavals, efficient food production is becoming the central task of the century. Investors who want to invest in this systemic transformation are positioning themselves at critical points in the value chain. Three key players, a chemical giant, a pioneer in biological solutions, and a specialist in soil health, show where the greatest opportunities lie. The strategies of BASF, MustGrow Biologics, and K+S provide the decisive blueprints for the future.
Read